期刊文献+

基于网络药理学从铁死亡途径探究七味参地颗粒治疗慢性肾小球肾炎的作用机制

Mechanism of Qiwei Shendi granules for chronic glomerulonephritis through ferroptosis pathway based on network pharmacology
下载PDF
导出
摘要 目的基于网络药理学和在体实验从铁死亡途径探究七味参地颗粒治疗慢性肾小球肾炎(CGN)的有效性及作用机制。方法运用GeneCards、OMIM、DrugBank数据库筛选CGN相关疾病靶点,TCMSP、HERB、BATMAN-TCM数据库筛选七味参地颗粒有效成分和靶标,FerrDb数据库筛选铁死亡相关靶点,利用Cytoscape软件构建了活性成分-作用靶点和蛋白质-蛋白质相互作用(PPI)网络图,使用R语言进行GO富集和KEGG通路分析,采用AutoDockTools 1.5.7进行分子对接分析,采用Western blot技术检测CGN小鼠肾脏组织中PPARA、MAPK14、HRAS和PTGS2的表达。结果筛选出1896个CGN疾病靶点,564个铁死亡靶点,33种七味参地颗粒药物活性成分,对应405个靶标,三者交集靶点共17个。采用MCODE,Degree,MCC,DMNC,MNC,EPC,EcCentricity,Closeness,Radiality,BottleNeck 10种算法筛选出PPARA、MAPK14、HRAS及PTGS2这4个核心靶蛋白,分子对接结果显示七味参地颗粒药物活性成分与核心靶蛋白均有良好的结合能力,动物实验结果表明七味参地颗粒可逆转4个核心靶蛋白的表达。结论七味参地颗粒可能通过调控PPARA、MAPK14、HRAS及PTGS2从铁死亡途径发挥治疗CGN的作用。 Objective To determine the effectiveness and mechanism of Qiwei Shendi granules in the treatment of chronic glomerulonephritis(CGN)via ferroptosis based on network pharmacology.Methods GeneCards,OMIM,DrugBank,TCMSP,HERB,BATMAN-TCM and FerrDb databases were screened to obtain CGN-related disease targets,active ingredients and targets of Qiwei Shendi granules and ferroptosis-related targets.Cytoscape software was used to construct network of proteinprotein interaction(PPI)and active component-action target.GO enrichment and KEGG pathways were conducted with R language.Molecular docking was performed with AutoDockTools 1.5.7.The expression of PPARA,MAPK14,HRAS and PTGS2 were determined in CGN-mice kidney tissues by Western blot.Results Totally 1896 CGN-related disease targets,564 ferroptosis targets,33 compounds and 405 targets from Qiwei Shendi granules were screened.Totally 17 intersected targets were obtained,which could be potentially therapeutic targets.Four core targets(PPARA,MAPK14,HRAS and PTGS2)in the network were screened with MCODE,Degree,MCC,DMNC,MNC,EPC,EcCentricity,Closeness,Radiality,and BottleNeck algorithms.All docking results showed that the key ingredients in Qiwei Shendi granules had strong binding activity with the core targets.In addition,the four core protein expression changes were reversed in CGN-mice after the treatment with Qiwei Shendi granules.Conclusion Qiwei Shendi granules in regulating CGN via ferroptosis may be related to PPARA,MAPK14,HRAS and PTGS2.
作者 徐先进 胡文杰 秦秀娟 XU Xian-jin;HU Wen-jie;QIN Xiu-juan(Department of Pharmacy,Hefei Ion Medical Center,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei 230088;Department of Pharmacy,The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine,Hefei 230031)
出处 《中南药学》 CAS 2024年第7期1692-1697,共6页 Central South Pharmacy
基金 国家自然科学基金青年项目(No.82104613)。
关键词 七味参地颗粒 慢性肾小球肾炎 网络药理学 铁死亡 分子对接 Qiwei Shendi granule chronic glomerulonephritis network pharmacology ferroptosis molecular docking
  • 相关文献

参考文献8

二级参考文献58

  • 1陈敬民,李友娣.金樱子醇提物对血清病型肾炎大鼠的药理作用[J].时珍国医国药,2006,17(8):1404-1405. 被引量:28
  • 2肖凯军,刘晓红.金樱子果实的化学成分及其应用[J].现代食品与药品杂志,2006,16(4):1-3. 被引量:63
  • 3陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2007:712-717.
  • 4Qiu H,Fu P,Fan W,et al.Treatment of primary chronic glomerulonephritis with Rehmannia glutinosa acteosides in combination with the Angiotensin receptor blocker irbesartan:a randomized controlled trial[J].Phytother Res,2014,28(1):132-136.
  • 5Danilewicz M,Wagrowska-Danilewicz M.The immunoexpression of glomerular NF-κB in proteinuric patients with proliferative and non-proliferative glomerulopathies[J].Pol J Pathol,2013,64(2):78-83.
  • 6Huang W,Xu L,Zhou X,et al.High glucose induces activation of NF-κB inflammatory signaling through IκBa sumoylation in rat mesangial cells[J].Biochem Biophys Res Commun,2013,438(3):568-574.
  • 7Toyokuni S,Tanaka T,Kawaguchi W,et al.Effects of the phenolic contents of Mauritian endemic plant extracts on promoter activities of antioxidant enzymes[J].Free Radic Res,2003,37(11):1215-1224.
  • 8Wardle E N.Cellular oxidative processes in relation to renal disease[J].Am J Nephrol,2005,25(1):13-22.
  • 9Bhatt S R,Lokhandwala M F,Banday A A.Vascular oxidative stress upregulates angiotensin II type I receptors via mechanisms involving nuclear factor kappa B[J].Clin Exp Hypertens,2014,36(6):367-373.
  • 10Brasier A R.The NF-kappa B regulatory network[J].Cardiovasc Toxicol,2006,6(2):111-130.

共引文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部